Cart
sales@molnova.com
Home - Products - Angiogenesis - FGFR - SKLB 610

SKLB 610

CAS No. 1125780-41-7

SKLB 610( SKLB610 | SKLB 610 | SKLB-610 )

Catalog No. M10442 CAS No. 1125780-41-7

SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 62 In Stock
5MG 36 In Stock
10MG 70 In Stock
25MG 116 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    SKLB 610
  • Note
    Research use only, not for human use.
  • Brief Description
    SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR.
  • Description
    SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 μM in biochemical kinase assays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SKLB610 | SKLB 610 | SKLB-610
  • Pathway
    Angiogenesis
  • Target
    FGFR
  • Recptor
    FGFR| PDGFR| VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1125780-41-7
  • Formula Weight
    415.37
  • Molecular Formula
    C21H16F3N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    O=C(NC)C1=NC=CC(OC2=CC=C(NC(C3=CC=CC(C(F)(F)F)=C3)=O)C=C2)=C1
  • Chemical Name
    N-methyl-4-(4-(3-(trifluoromethyl)benzamido)phenoxy)picolinamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shah A, Mangaonkar A. Ann PharmacOthers. 2015 Jul 16.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • TAS120

    TAS-120 is a novel potent and highly selective FGFR inhibitor used for antitumor treatment.

  • Aprutumab

    Aprutumab (BAY 1179470) is a human FGFR2 monoclonal antibody with affinity to FGFR2 isoforms FGFR2-IIIB and FGFR2-IIIC. Aprutumab is commonly used to synthesize antibody-drug conjugates.

  • FGFR4-IN-1

    FGFR4-IN-1 is a potent FGFR4 inhibitor (IC50: 0.7 nM).

Sign In Join Free